Compare Ginkgo Bioworks Holdings Inc (DNA) vs Western Digital Corp (WDC) Price & Performance

Ginkgo Bioworks (DNA) trades at $12.84, up 11.94% in the last session. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million in 2025 on $170.16 million revenue, with a negative net margin of 219.6%. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting strategic growth initiatives despite financial challenges.

Outlook remains speculative with high risk. The buy/hold/sell analyst split is nearly even, reflecting uncertainty. Significant cash burn and persistent losses pose substantial risks, but partnerships and government contracts offer potential catalysts. Investors should weigh the company's long-term biotechnology prospects against its current lack of profitability and negative cash flow.

Western Digital (WDC) trades at $394.13, down 2.73% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with three consecutive earnings beats and robust profitability metrics including 71.97% net margin and 131.02% ROE. Technical indicators are bearish with the price testing key support at $387, while analyst consensus remains strongly bullish with a $647.58 price target representing 64% upside potential.

Despite near-term competitive pressures, WDC's dominant market position in AI storage and improving financial performance support long-term growth prospects. Key risks include pricing pressure from increased industry capacity and execution challenges in maintaining cost-per-terabyte reductions. The current valuation at 14.61 P/E appears attractive relative to growth expectations.